subject: Stock Update On Prot, Nvda, Stri From Pennytobuck.com [print this page] Proteonomix, Inc., (OTCBB:PROT.OB) a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives, announced on August 6, that it has formed a new subsidiary called X Gen Medical LLC, a Nevis Virgin Island entity. X Gen Medical has been established with the intention of conducting business in the global medical marketplace. Proteonomix plans on utilizing X Gen Medical to serve as a platform for joint ventures with medical facilities worldwide. It is anticipated that new relationships formed with X Gen Medical will create medical facilities capable of not just attracting treatments locally, but also acting as hubs for medical tourism. Medical tourism is constantly on the rise and anticipated to continue to grow substantially due to current high costs of health care for certain procedures and improvements in both technology and standards of care in many countries.
Proteonomix is a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives. Proteoderm, Inc. a wholly owned subsidiary of Proteonomix that has recently opened its retail web site, Proteoderm.com, and begun accepting pre-orders for its anti-aging line of skin care products.
StromaCel, Inc.s goal is the development therapeutic modalities for the treatment of Cardiovascular Disease. StromaCel, Inc. is pursuing the licensing of other technologies for therapeutic use. National Stem Cell, Inc. is Proteonomixs operating subsidiary. The Sperm Bank of New York, Inc. is a fully operational tissue bank. Proteonomix Regenerative Translational Medicine Institute, Inc. intends to focus on the translation of promising research in stem cell biology and cellular therapy to clinical applications of regenerative medicine. Proteonomix intends to create and dedicate a subsidiary to each of its technologies.
NVIDIA Corporation (NASDAQ:NVDA) has introduced the NVIDIA GeForce 400M series of graphics processing units (GPUs) -- the building blocks for the next-generation of NVIDIA Optimus and NVIDIA 3D Vision notebooks that are coming onto the market from leading vendors, including Acer, Asus, Dell, Lenovo, Samsung and Toshiba, with others set to announce soon.
The new series of NVIDIA GeForce 400M GPUs includes:
* For enthusiast users: GeForce GTX 470M and GTX 460M.
* For performance users: GeForce GT 445M, GT 435M, GT 425M, GT 420M and GT 415M.
The GeForce 400M series is also able to deliver breathtaking stereoscopic 3D images for gamers, movie-lovers and photo enthusiasts when configured with NVIDIA 3D Vision glasses and a 3D display. 3D Vision supports the richest array of 3D content available, including over 425 games, Blu-ray 3D movies, photos and streaming Web video. Notebook models featuring the GeForce 400M series and NVIDIA 3D Vision glasses will be available soon after launch, including the Acer Aspire 5745DG with GeForce GT 425M and the Asus G53Jw with GeForce GTX 460M. In addition, by including support for NVIDIA 3DTV Play, consumers can attach their notebook to a brand new 3D TV and enjoy all the latest 3D content including the hottest games in the comfort of their living room.
NVIDIA awakened the world to the power of computer graphics when it invented the GPU in 1999. Since then, it has consistently set new standards in visual computing with breathtaking, interactive graphics available on devices ranging from tablets and portable media players to notebooks and workstations. NVIDIA's expertise in programmable GPUs has led to breakthroughs in parallel processing which make supercomputing inexpensive and widely accessible. The company holds more than 1,100 U.S. patents, including ones covering designs and insights which are fundamental to modern computing. For more information, see www.nvidia.com.
STR Holdings, Inc. (NYSE:STRI) recently announced the appointment of Bernardo E. Alvarez, 46, to the position of Director of Business Development STR Solar for the Peoples Republic of China.
Mr. Alvarez has served as General Manager of Specialized Technology Resources Espaa, S.A., (STRE), Llanera, Asturias, Spain, since its inception in 2002. Prior to joining STRE, Mr. Alvarez was employed by multinational Rioglass, S.A., as a Plant Manager. Prior to Rioglass, Mr. Alvarez held professional positions of increasing responsibility in engineering and project management with INGEMAS, S.A., an engineering consulting firm specializing in the design and construction of turnkey production facilities in the Energy, Mining and Construction Materials Industries. Mr. Alvarez holds an advanced degree in Mining Engineering/Metallurgy from the University of Oviedo as well as a Masters Certificate in Business Administration from CECAP Asturias.
STR Holdings, Inc. is a leading global provider of high quality, superior performance solar encapsulants to the photovoltaic module industry. It is also one of the worlds leading providers of consumer product quality assurance testing, audit, inspection and responsible sourcing services, which help ensure that suppliers and retailers have the highest level of confidence in the quality and safety of their products and in the social standards of the supply chain producing them. Further information about STR Holdings, Inc. can be obtained via the Companys website at www.strholdings.com.
For FREE Daily Stock Alerts & Updates Signup At: http://pennytobuck.com/signup
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PennyToBuck.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.Our disclaimer ( http://pennytobuck.com/disclaimer) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold PennyToBuck.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations.The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received twenty thousand dollars in cash and twenty thousand dollars in free trading shares from a third party (Swiss Financial Report) for (30) days of advertisement services for Proteonomix, Inc. (PROT.OB)
